Published in Immunotherapy Weekly, September 1st, 2004
The 5-year warrants are exercisable at a price of $2.86 per share. Subject to customary closing conditions, the private placement is scheduled to close during the first week of August 2004.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Immunotherapy Weekly